Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Publication : liver international

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B.

Authors : Lim, Jihye¹ (AUTHOR); Choi, Won‐Mook¹ (AUTHOR); Shim, Ju Hyun¹ (AUTHOR)

Source: Liver International. Jul2022, Vol. 42 Issue 7, p1517-1527. 11p. 2 Charts, 4 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Nucleos(t)ide analogue therapy: The role of tenofovir alafenamide.

Authors : Buti, Maria^1,2 (AUTHOR) ; Marcos‐Fosch, Cristina¹ (AUTHOR); Esteban, Rafael^1,2 (AUTHOR)

Source: Liver International. Jun2021 Supplement S1, Vol. 41, p9-14. 6p. 1 Chart.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.

Authors : Ogawa, Eiichi¹ (AUTHOR) ; Nomura, Hideyuki^2,3 (AUTHOR); Nakamuta, Makoto⁴ (AUTHOR)

Source: Liver International. Jul2020, Vol. 40 Issue 7, p1578-1589. 12p. 4 Charts, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B.

Authors : Jung, Chan‐Young¹ (AUTHOR); Kim, Hyung Woo¹ (AUTHOR); Ahn, Sang Hoon^1,2,3 (AUTHOR)

Source: Liver International. May2022, Vol. 42 Issue 5, p1017-1026. 10p. 1 Diagram, 4 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.

Authors : Jung, Chan‐Young¹ (AUTHOR); Kim, Hyung Woo¹ (AUTHOR); Lee, Jung Il² (AUTHOR)

Source: Liver International. Nov2022, Vol. 42 Issue 11, p2408-2417. 10p. 1 Diagram, 3 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes.

Authors : Samadi Kochaksaraei, Golasa¹ (AUTHOR); Shaheen, Abdel A.^1,2 (AUTHOR); Seow, Cynthia H.^1,2 (AUTHOR)

Source: Liver International. Aug2022, Vol. 42 Issue 8, p1712-1730. 19p. 9 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study.

Authors : Park, Jun Yong^1,2; Kim, Chang Wook^2,3; Bae, Si Hyun^2,4

Source: Liver International. Aug2016, Vol. 36 Issue 8, p1108-1115. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low‐level viraemia.

Authors : Li, Zhong‐Bin¹ (AUTHOR); Li, Le² (AUTHOR); Niu, Xiao‐Xia¹ (AUTHOR)

Source: Liver International. Jun2021, Vol. 41 Issue 6, p1254-1264. 11p. 2 Diagrams, 3 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Authors : Baran, Bulent¹; Soyer, Ozlem Mutluay²; Ormeci, Asli Cifcibasi²

Source: Liver International. Oct2015, Vol. 35 Issue 10, p2265-2274. 10p. 3 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

Authors : Fung, Scott¹; Gordon, Stuart C.²; Krastev, Zahary³

Source: Liver International. Feb2015, Vol. 35 Issue 2, p422-428. 7p. 2 Charts, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B.

Nucleos(t)ide analogue therapy: The role of tenofovir alafenamide.

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.

Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B.

Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.

Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission—A review of maternal and infant outcomes.

Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study.

Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low‐level viraemia.

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

اتصل بنا

اتبع